La Recherche scientifique au service de nos patients

Les publications du LBMBM:

Equipe1:

  1. Outcomes of patients with advanced clear-cell renal cell carcinoma treated by sunitinib as firstline therapy: A prospective observational study in real-world practice of the Academic Hospital of Oran, Algeria. Arab Journal of Urology, 16:sup1, S34-S35, DOI: 10.1016/j.aju.2018.10.026
  2. Cancer du nasopharynx dans l'Ouest algérien résultas à long terme et facteurs pronostiques dans une cohorte de 200 cas. Cancer radiothérapie 10.1016/j.canard.2011.07.073
  3. Carcinoma of the basis of the tongue at the woman and the incrimination of tooth fillings about a case. PAJO 2016,9(2):12
  4. A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma. Clin Oncol 29: 2011 (suppl; abstr 5543)
  5. Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: Current status. Journal of Cancer Research and Therapeutics, Vol. 5, No. 1, January-March, 2009, pp. 3-7
  6. A comparative study of gemcitabine/doxorubicin and cyclophosphamide/doxorubicin combinations in first-line metastatic breast cancer. Journal of Clinical. Oncology26(15)DOI:10.1200/jco.2008.26.15_suppl.1050
  7. Expression C-Kit dans les carcinomes du nasopharynx. Cancer/RadiothérapieVolume 13, Issues 6-7, October 2009, Page 678.
  8. Combination of gemcitabine and carboplatin chemotherapy for recurrent nasopharyngeal carcinoma. jco.2010.28.15_suppl.e16006
  9. A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.JCO.2011.29.15_SUPPL.5543Corpus ID: 3219554
Equipe 2:

  1. Impact of the major BCR-ABL1 transcript type on clinical and biological parameters and molecular response in patients with chronic myeloid leukemia. Hematology/oncology and stem cell therapy. 2020:S1658-3876 (20) 30145-X.DOI: 10.1016/j.hemonc.2020.08.003
  2. Sex and major molecular response to imatinib treatment in patient with chronic myeloid leukemia.Journal Biochemistry and Pharmacology. Biochem Pharmacol(Los Angel) 2019, 8:1DOI: 10.4172/2167-0501.1000263
  3. The proportion of different BCR-ABL1 transcrit types in chronic myeloid leukemia . An international overview . SPRINGER NATURE 2019. Doi.org/10.1038/s41375-018-0341-4
  4. Abstract. Etude moléculaire du transcrit BCR-ABL1 : Place de la RT-PCR multiplex »Revue Société Française d'Hématologie. Volume 22, supplément 1, Mars 2016. Page 204.Abstracts SFH 2016https://www.jle.com/fr/revues/hma/edocs/15_leucemie_myeloide_chronique_biologie_et_clinique__306714/article.phtml?tab=supp
  5. Evaluation of the Imatinib Treatment of Patients with Chronic Myeloid Leukemia (CML). a Retrospective Study from Algerian Working Group on CML (GAT-LMC)American Society of HematologyBlood 2016 ; vol. 128 no. 22 5454ISSN : 1528-0020.
  6. Outcome of Frontline Treatment with Generic Imatinib in Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A First Multicenter StudyAmerican Society of HematologyBlood 2016 ; vol. 128 no. 22 1899ISSN : 1528-0020.
  7. Facteurs prédictifs de la réponse moléculaire majeure chez les patients atteints de leucémie myéloïde chronique en phase chronique traités par Imatinib dans l'ouest AlgérienRevue Société Française d'Hématologie.Volume 23, supplément 2, Mars 2017. Page 213.Abstracts SFH 2017https://www.jle.com/fr/revues/hma/e-docs/15_leucemie_myeloide_chronique_biologie_et_clinique_309239/article.phtml?tab=supp
  8. LE TRANSCRIT DE FUSION BCR-ABL1 : INTÉRÊT DE LA QUANTIFICATION PAR LA QRT-PCRDANS LE DIAGNOSTIC ET LE SUIVI MOLÉCULAIRE DE LA MALADIE RÉSIDUELLE CHEZ LES PATIENTS ATTEINTS DE LEUCÉMIE MYÉLOÏDE CHRONIQUE TRAITÉS PAR IMATINIB MESYLATE.17 Décembre 2017.M Nachihttps://theses.univ-oran1.dz/document/1012017021t.pdf

Equipe3:

  1. Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series. International journal of molecular sciences. Int. J. Mol. Sci. 2016, 17(5), 743 .https://www.ncbi.nlm.nih.gov/pmc/articles/PMC488156

Equipe 4:

  1. Biomarkers of Inflammation and Oxidative Stress in Renal Transplant Patients: Relation with Glomerular Filtration Rate.https://www.transylvanianreviewjournal.org/index.php/TR/article/view/3887
  2. Effects of CYP3A5 and ABCB1 Genetics Variant on Tacrolimus Pharmacokinetics in Algerian adult Kidney Transplant Patients.Boudia, F ;Hamdani A, JMSCR ." journal of medical science and clinical research (2016)Volume 04 Issue 04 April 2016 https://216.10.240.19/v4-i4/34%20jmscr.pdf
  3. Amrani-Midoun, A., Adlam, D., Bouatia-Naji, N., (2021). Recent Advances on the Genetics of Spontaneous Coronary Artery Dissection. Circulation ; Genomic and Precision Medicine 121.003393. https://doi.org/10.1161/CIRCGEN.121.003393
  4. Amrani-Midoun, A., et al. (2019). Genetic association study between -T786C NOS3 polymorphism and essential hypertension in an Algerian population. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13 (2), 1317-1320.
  5. Amrani-Midoun, A., et al. (2016). The relationship between MTHFR C677T gene polymorphism and essential hypertension in a sample of an Algerian population of the Oran city. International Journal of Cardiology, 225C, 408-411 doi: 10.1016/j.ijcard.2016.10.027 ( IF= 4.63)
  6. Amrani, A., et al. (2015). Association study between some renin-angiotensin system gene variants and essential hypertension in a sample of Algerian population: case control study.Annales de Biologie Clinique, 73, 557-563. doi: 10.1684/abc.2015.1069
  7. Amrani, A., Lamara, S.C., Attab, K., Ziani, M. ( 2015). Relationship between Asthma and Essential Hypertension. Special issue of the Annals of Clinic and Laboratory Research, Nguyen Van Bang, (Hanoi Medical University (Eds), S1.
  8. Amrani, A., Mesli TalebBendieb, F., BabaHamed, M. B. (2014). Relationship between Angiotensinogen gene T174M Polymorphism and Essential Hypertension in a Sample of Algerian Population: Case Control Study. Journal of Medical Sciences, 14, 168-173. doi: jms.2014.168.173
  9. Amrani, A. (2013). Genetics of hypertension: the lack of evidence. Annals of Clinic and Laboratory Research, 1, 1:3. doi: 10.3823/140



Créez votre site web gratuitement ! Ce site internet a été réalisé avec Webnode. Créez le votre gratuitement aujourd'hui ! Commencer